Thrombocytopenia in a Neonate

Reed, Maria A. B.; Rikabi, Nada; Krugh, Dave; Dietrich, Sandra; Rossi, Karen; Knudtson, Eric; Shaughnessy, Richard O'; Kennedy, Melanie S.

doi:10.1309/a6vh2bbehypnfbcn

Cited by 1 publication

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Late-onset thrombocytopenia may be related to more diverse causes including bacterial and viral infections, systemic inflammation, hepatitis, necrotizing enterocolitis, and sometimes, may be iatrogenic due to thrombi in central lines or may develop as adverse drugs of certain drugs. [12][13][14][15][16][17][18][19][20][21][22][23][24][25][26] Genetic disorders with bone marrow dysfunction are less frequent, but can appear at any age. [27][28][29] Baer et al 23 examined 11281 NICU admissions and identified severe thrombocytopenia in 273 (2.4%).…”

Section: Normal Platelet Counts I N Neonatesmentioning

confidence: 99%

Approach to Neonatal Alloimmune Thrombocytopenia: The Perspective from a Transfusion Medicine Service

Maheshwari¹,

Sharma²,

Sharma³

2022

Newborn

View full text Add to dashboard Cite

Neonatal alloimmune thrombocytopenia (NAIT) is an important hematological disorder in neonates. The pregnant mother's immune system gets sensitized to antigens expressed on fetal platelets that have been inherited from the father and begins producing specific alloantibodies against these antigens. Some of these antibodies get transported across the placenta into the baby and can damage/destroy platelets to cause fetal/neonatal thrombocytopenia. Many of these fetuses/infants develop major clinical complications such as intracranial hemorrhages. In this article, we describe normal platelet counts in neonates, the pathogenesis and epidemiology of NAIT, specific platelet antigens that have been identified as targets in NAIT, and the approach for laboratory diagnosis of NAIT. From the perspective of a transfusion medicine service, there are two targets as follows: (a) To identify the differences in the antigenic profiles of the platelets of the mother and her fetus/infant and (b) To detect alloantibodies in the maternal serum that may be specifically reactive to these platelet antigens. Early identification of NAIT can help timely institution of appropriate treatment. In this project, we reviewed the laboratory profiles of infants who were diagnosed to have NAIT at our own institution and also mined the literature in the databases EMBASE, PubMed, and Scopus.

show abstract